Brief alcohol support for people on buprenorphine
Part of Mental health clinical trials.
This trial tests a brief alcohol-focused support program designed for people who are already taking buprenorphine for opioid addiction. The goal is to help you reduce your drinking in a way that fits with your current treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been taking buprenorphine (a medication for opioid addiction) for at least 2 weeks.
- You have alcohol use disorder (trouble controlling your drinking, and it causes problems in your life).
- You drink alcohol on average at least 1 day a week in the past month.
- You can read simple English.
- You are not currently in another treatment program for alcohol, and you do not have psychosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is focused on people who are currently getting treatment for substance use disorder. It aims to test community partnership approaches that reduce barriers and improve support during recovery.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This study tests a new way to support patients taking buprenorphine-naloxone for opioid addiction. It uses regular check-ins to help you and your doctor stay on track with your treatment.
This study tests a program that helps people on buprenorphine for opioid use disorder build a stronger foundation for recovery. Participation may provide extra support and resources to help you stay on track.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.